Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$467.4M
-33.0% from 2023
Prescriptions
1.6M
$287.10 per claim
Patients
1.6M
60,636 prescribers
Total spending, 2024
$467.6M
$288.43 per patient
Medicare prescription drug plans paid $467.4M for Abrysvo in 2024, for 1,628,085 prescriptions and refills to 1,620,554 patients (down 33.0% from 2023). The average cost per claim was $287.10.
California had the highest Medicare cost for Abrysvo in 2024: $37.3M for 138,993 claims, followed by Illinois ($35.1M).
Marc R Watkins, preventive medicine in Nashville, TN, had the highest Medicare cost for Abrysvo in 2024: 70,775 claims costing $21.8M.
Abrysvo is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm, Pfizer Labs..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Marc R Watkins Nashville, TN | Preventive Medicine | 70,775 | 70,571 | $21.8M |
| Cedric E Davis II Parker, AZ | Family Practice | 56,657 | 56,471 | $14.5M |
| Armaghan Azad |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 54,096 | 2,133,393 | 2,131,320 | $698.0M |
| 2024 | 60,636 | 1,628,085 | 1,620,554 | $467.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Emergency Medicine |
| 52,415 |
| 52,299 |
| $14.1M |
| Rushdi Alul Chicago, IL | Emergency Medicine | 43,313 | 43,195 | $12.2M |
| Richard D Clark Marietta, OH | Family Practice | 33,780 | 33,681 | $9.6M |
| Annette V Wagner Wilkes Barre, PA | Obstetrics & Gynecology | 30,004 | 29,894 | $8.8M |
| Lindsay M Weaver Indianapolis, IN | Emergency Medicine | 31,307 | 31,211 | $8.7M |
| Daniel R Bauer Charlotte, NC | Internal Medicine | 30,208 | 30,152 | $8.2M |
| Ruth E Mays Highland Park, MI | Family Practice | 27,785 | 27,731 | $8.1M |
| Shaun D Gill Doylestown, PA | Hospitalist | 24,405 | 24,342 | $7.1M |
| John R Bogdasarian Fitchburg, MA | Otolaryngology | 24,213 | 24,159 | $6.9M |
| Jason A Torrente Hamilton, NJ | Family Practice | 24,935 | 24,861 | $6.7M |
| Lloyd P Vanwinkle Castroville, TX | Family Practice | 21,474 | 21,347 | $6.4M |
| Jai G Wadhwani Williamsville, NY | Cardiology | 20,064 | 20,043 | $5.5M |
| Karen M Donaldson Baltimore, MD | Family Practice | 17,510 | 17,422 | $5.2M |
| Anthony J Oliva Jr. San Antonio, TX | Internal Medicine | 20,344 | 20,291 | $5.1M |
| Melissa D Tonn Dallas, TX | Preventive Medicine | 16,534 | 16,479 | $5.1M |
| Ikenna S Nzeogu Tazewell, VA | Internal Medicine | 17,732 | 17,699 | $5.0M |
| Martin A Duclos Conway, SC | Internal Medicine | 17,801 | 17,772 | $4.8M |
| Kathleen Sheridan Pittsburgh, PA | Infectious Disease | 13,925 | 13,904 | $4.2M |
| Carisa L Hines Atlanta, GA | Hospitalist | 12,489 | 12,468 | $3.9M |
| Zeiad A Fakhouri Hopewell Junction, NY | Family Practice | 13,726 | 13,705 | $3.7M |
| Eldridge G Burns Jr. Seward, NE | Family Practice | 12,805 | 12,787 | $3.3M |
| Janelle Duah Bridgeport, CT | Internal Medicine | 11,651 | 11,632 | $3.1M |
| Erika A Whelan Louisville, KY | Nurse Practitioner | 9,366 | 9,317 | $2.9M |
| Spending |
|---|
| Pfizer US Pharm PFE | 1,407,668 | $402.4M |
| Pfizer Labs. PFE | 220,894 | $65.1M |